|
ZNF440 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.692070E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.192200E-01 |
| Normal-vs-Stage2 |
2.482600E-01 |
| Normal-vs-Stage3 |
1.751730E-04 |
| Normal-vs-Stage4 |
1.355630E-04 |
| Stage1-vs-Stage2 |
2.542200E-01 |
| Stage1-vs-Stage3 |
4.11390000000234E-05 |
| Stage1-vs-Stage4 |
7.76380000000465E-05 |
| Stage2-vs-Stage3 |
1.458620E-01 |
| Stage2-vs-Stage4 |
9.399800E-02 |
| Stage3-vs-Stage4 |
6.524800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.009800E-02 |
| Normal-vs-AfricanAmerican |
6.943500E-03 |
| Normal-vs-Asian |
4.251000E-01 |
| Caucasian-vs-AfricanAmerican |
2.295400E-01 |
| Caucasian-vs-Asian |
8.765800E-02 |
| AfricanAmerican-vs-Asian |
3.477700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.087900E-02 |
| Normal-vs-Female |
4.446100E-02 |
| Male-vs-Female |
9.020600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.230780E-01 |
| Normal-vs-Age(41-60Yrs) |
1.316980E-01 |
| Normal-vs-Age(61-80Yrs) |
2.277400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.658200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.049600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.060600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.406400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.928200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.727600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.206200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.967600E-01 |
| Normal-vs-Grade 2 |
6.053400E-01 |
| Normal-vs-Grade 3 |
1.086150E-02 |
| Normal-vs-Grade 4 |
1.679899996887E-08 |
| Grade 1-vs-Grade 2 |
2.001600E-01 |
| Grade 1-vs-Grade 3 |
2.940300E-02 |
| Grade 1-vs-Grade 4 |
8.719500E-03 |
| Grade 2-vs-Grade 3 |
1.754050E-02 |
| Grade 2-vs-Grade 4 |
6.47889997207329E-09 |
| Grade 3-vs-Grade 4 |
1.432840E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.241200E-01 |
| Normal-vs-ccB subtype |
9.70449999999623E-05 |
| ccA subtype-vs-ccB subtype |
1.45709999621602E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.118300E-02 |
| Normal-vs-N1 |
7.241500E-04 |
| N0-vs-N1 |
5.516100E-02 |
|
|
